ASC4FIRST Trial Supports Asciminib With Secondary End Points in CML ...

Here are the top 5 articles from 2024 reported on Oncology Nursing News. Opinion: The Media May Have Oversold AOH1996, City ...

Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's ...

Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's ...

Medical experts discuss strategies for patient education on managing potential adverse events of lorlatinib and other ALK ...

Panelists discuss how amivantamab’s dual targeting of EGFR and MET may address resistance mechanisms and unmet needs in ...

Treatment sequencing with targeted therapies may help to improve overall survival, according to real-world data.

The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of ...

The study's findings have implications for early detection and prevention of breast cancer, suggesting that chromosomal ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

This past year, the role of ctDNA testing has expanded to guide treatment decisions for providers and patients with cancer.

Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...